Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Offering a robust, cloud-centric platform, comprehensive longitudinal electronic health record (EHR) data, and advanced analytical tools, this system assists healthcare providers and life sciences organizations in discovering new relationships among previously isolated healthcare information. It comprises a suite of software-as-a-service (SaaS) applications that facilitate swift population management, performance evaluation, and meaningful engagement with both patients and providers. This solution allows healthcare organizations to gather, link, and merge information from numerous varied sources across their entire enterprise and clinically integrated networks. It empowers designers of care and quality programs to effectively search and explore populations related to diagnoses, treatments, outcomes, costs, and demographics. Furthermore, it swiftly pinpoints target populations, enabling improved decision-making regarding risk-stratified care management. Additionally, it presents an integrated framework that correlates vast amounts of clinical, operational, and financial events into benchmarks and scorecards for insightful comparisons, ultimately enhancing the overall quality of care delivered. This comprehensive approach not only streamlines data integration but also supports innovative healthcare solutions.
Description
Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
IBM
Founded
1911
Country
United States
Website
www.ibm.com/watson-health/about/explorys
Vendor Details
Company Name
IPM.ai
Country
United States
Website
www.ipm.ai/platform
Product Features
Electronic Medical Records (EMR)
Appointment Management
Charting
Compliance Tracking
E-Prescribing
E/M Coding
HIPAA Compliant
Handwriting Recognition
Integrated Telehealth
MIPS Certified
Meaningful Use Certified
ONC-ATCB Certified
Patient Portal
Self Service Portal
Voice Recognition